ArticleFrontiers in immunology2026
Monocyte-plasma cell communication characterizes treatment-associated peripheral immune remodeling in Guillain-Barré syndrome.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Guillain -Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy involving multifaceted pathogenic mechanisms. Although humoral immunity is central to GBS pathogenesis, longitudinal changes in peripheral immune circuits across symptomatic disease and clinical recovery remain incompletely understood at single-cell resolution. Methods: We performed longitudinal single-cell RNA sequencing of peripheral blood mononuclear cells collected during the symptomatic GBS and clinical recovery phases from a patient with GBS. Changes in immune cell composition, transcriptional programs, intercellular communication, and gene regulatory networks were examined, with particular attention to plasma cells, monocytes, B cells, and putative double-negative T cells (DNTs). Results: Plasma cells, monocytes, and putative DNTs exhibited stage-dependent transcriptional remodeling. During the GBS phase, plasma cells exhibited increased secretory and IgG-associated programs, consistent with enhanced antibody-producing activity. Monocytes represented higher relative proportion and showed enrichment of antigen-presentation and inflammatory pathways. Cell -cell communication analysis indicated stronger inferred BAFF and APRIL signaling from monocytes toward B cells and plasma cells during the GBS phase, suggesting a potential monocyte contribution to humoral activation. Regulatory network analysis identified SPI1-associated activity within the inflammatory monocyte program. In parallel, putative DNTs showed comparatively higher inferred outgoing cytokine signaling together with enrichment of ribosome biogenesis and protein synthesis pathways. During recovery, plasma cell secretory signatures were attenuated. B cells upregulated memory- and regulatory-associated genes, inflammatory monocyte programs diminished, and inferred DNT-associated cytokine signaling was lower in the recovery sample, accompanied by receptor-mediated and adhesion-related transcriptional programs. Conclusion: Collectively, these findings provide a longitudinal single-cell view of peripheral immune remodeling in GBS and highlight a stage-associated monocyte -B-cell regulatory axis and differences in DNT-associated inferred cytokine signaling between the GBS and recovery samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.